Skip to main content
SpringerLink
Log in

The Marginal Liver Donor and Organ Preservation Strategies

  • Chapter
  • First Online:
Liver Anesthesiology and Critical Care Medicine

Abstract

According to the United Network for Organ Sharing (UNOS) data, as of December 2010, 4,448 liver transplants have been performed with 16,118 patients on the waiting list in the same year [1]. The advances in patient and donor selection, surgical techniques, immunosuppression, organ preservation, and critical care management have made lifesaving liver transplantation possible to those with irrevocable liver damage and acute liver failure. Yet the scarcity of organs continues to be a major obstacle to greater application of liver transplantation (Fig. 15.1).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. United Network for Organ Sharing. Accessed at http://www.unos.org December 2012.

  2. Emre S, Schwartz ME, Altaca G, et al. Safe use of hepatic allografts from donors older than 70 years. Transplantation. 1996;62:62–5.

    Article  PubMed  CAS  Google Scholar 

  3. Oh CK, Sanfey HA, Pelletier SJ, Sawyer RG, McCullough CS, Pruett TL. Implication of advanced donor age on the outcome of liver transplantation. Clin Transplant. 2000;14:386–90.

    Article  PubMed  CAS  Google Scholar 

  4. Wall WJ, Mimeault R, Grant DR, Bloch M. The use of older donor livers for hepatic transplantation. Transplantation. 1990;49:377–81.

    Article  PubMed  CAS  Google Scholar 

  5. Hoofnagle JH, Lombardero M, Zetterman RK, et al. Donor age and outcome of liver transplantation. Hepatology. 1996;24:89–96.

    Article  PubMed  CAS  Google Scholar 

  6. Rull R, Vidal O, Momblan D, et al. Evaluation of potential liver donors: limits imposed by donor variables in liver transplantation. Liver Transpl. 2003;9:389–93.

    Article  PubMed  Google Scholar 

  7. Rayhill SC, Wu YM, Katz DA, et al. Older donor livers show early severe histological activity, fibrosis, and graft failure after liver transplantation for hepatitis C. Transplantation. 2007;84:331–9.

    Article  PubMed  Google Scholar 

  8. Mutimer DJ, Gunson B, Chen J, et al. Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus. Transplantation. 2006;81:7–14.

    Article  PubMed  Google Scholar 

  9. Condron SL, Heneghan MA, Patel K, Dev A, McHutchison JG, Muir AJ. Effect of donor age on survival of liver transplant recipients with hepatitis C virus infection. Transplantation. 2005;80:145–8.

    Article  PubMed  Google Scholar 

  10. Alkofer B, Samstein B, Guarrera JV, et al. Extended-donor criteria liver allografts. Semin Liver Dis. 2006;26:221–33.

    Article  PubMed  Google Scholar 

  11. Takeda Y, Arii S, Kaido T, et al. Morphologic alteration of hepatocytes and sinusoidal endothelial cells in rat fatty liver during cold preservation and the protective effect of hepatocyte growth factor. Transplantation. 1999;67:820–8.

    Article  PubMed  CAS  Google Scholar 

  12. Fukumori T, Ohkohchi N, Tsukamoto S, Satomi S. Why is fatty liver unsuitable for transplantation? Deterioration of mitochondrial ATP synthesis and sinusoidal structure during cold preservation of a liver with steatosis. Transplant Proc. 1997;29:412–5.

    Article  PubMed  CAS  Google Scholar 

  13. Lemasters JJ, Peng XX, Bachmann S, Currin RT, Gao W, Thurman RG. Dual role of Kupffer cell activation and endothelial cell damage in reperfusion injury to livers stored for transplantation surgery. J Gastroenterol Hepatol. 1995;10 Suppl 1:S84–7.

    Article  PubMed  Google Scholar 

  14. Markin RS, Wisecarver JL, Radio SJ, et al. Frozen section evaluation of donor livers before transplantation. Transplantation. 1993;56:1403–9.

    Article  PubMed  CAS  Google Scholar 

  15. Fishbein TM, Fiel MI, Emre S, et al. Use of livers with microvesicular fat safely expands the donor pool. Transplantation. 1997;64:248–51.

    Article  PubMed  CAS  Google Scholar 

  16. Trevisani F, Colantoni A, Caraceni P, Van Thiel DH. The use of donor fatty liver for liver transplantation: a challenge or a quagmire? J Hepatol. 1996;24:114–21.

    Article  PubMed  CAS  Google Scholar 

  17. Porte RJ, Ploeg RJ, Hansen B, et al. Long-term graft survival after liver transplantation in the UW era: late effects of cold ischemia and primary dysfunction. European Multicentre Study Group. Transpl Int. 1998;11 Suppl 1:S164–7.

    PubMed  Google Scholar 

  18. Ploeg RJ, D’Alessandro AM, Knechtle SJ, et al. Risk factors for primary dysfunction after liver transplantation–a multivariate analysis. Transplantation. 1993;55:807–13.

    Article  PubMed  CAS  Google Scholar 

  19. Scotte M, Dousset B, Calmus Y, Conti F, Houssin D, Chapuis Y. The influence of cold ischemia time on biliary complications following liver transplantation. J Hepatol. 1994;21:340–6.

    Article  PubMed  CAS  Google Scholar 

  20. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med. 2000;342:605–12.

    Article  PubMed  CAS  Google Scholar 

  21. Yersiz H, Shaked A, Olthoff K, et al. Correlation between donor age and the pattern of liver graft recovery after transplantation. Transplantation. 1995;60:790–4.

    PubMed  CAS  Google Scholar 

  22. Castells L, Vargas V, Rodriguez-Frias F, et al. Transmission of hepatitis B virus by transplantation of livers from donors positive for antibody to hepatitis B core antigen. Transplant Proc. 1999;31:2464–5.

    Article  PubMed  CAS  Google Scholar 

  23. Uemoto S, Inomata Y, Sannomiya A, et al. Posttransplant hepatitis B infection in liver transplantation with hepatitis B core antibody-positive donors. Transplant Proc. 1998;30:134–5.

    Article  PubMed  CAS  Google Scholar 

  24. Wachs ME, Amend WJ, Ascher NL, et al. The risk of transmission of hepatitis B from HBsAg(−), HBcAb(+), HBIgM(−) organ donors. Transplantation. 1995;59:230–4.

    PubMed  CAS  Google Scholar 

  25. Dickson RC, Everhart JE, Lake JR, et al. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Gastroenterology. 1997;113:1668–74.

    Article  PubMed  CAS  Google Scholar 

  26. Roche B, Samuel D, Gigou M, et al. De novo and apparent de novo hepatitis B virus infection after liver transplantation. J Hepatol. 1997;26:517–26.

    Article  PubMed  CAS  Google Scholar 

  27. Dodson SF, Issa S, Araya V, et al. Infectivity of hepatic allografts with antibodies to hepatitis B virus. Transplantation. 1997;64:1582–4.

    Article  PubMed  CAS  Google Scholar 

  28. Uemoto S, Sugiyama K, Marusawa H, et al. Transmission of hepatitis B virus from hepatitis B core antibody-positive donors in living related liver transplants. Transplantation. 1998;65:494–9.

    Article  PubMed  CAS  Google Scholar 

  29. Nery JR, Gedaly R, Vianna R, et al. Are liver grafts from hepatitis B surface antigen negative/anti-hepatitis B core antibody positive donors suitable for transplantation? Transplant Proc. 2001;33:1521–2.

    Article  PubMed  CAS  Google Scholar 

  30. Joya-Vazquez PP, Dodson FS, Dvorchik I, et al. Impact of anti-hepatitis Bc-positive grafts on the outcome of liver transplantation for HBV-related cirrhosis. Transplantation. 2002;73:1598–602.

    Article  PubMed  Google Scholar 

  31. Loss GE, Mason AL, Blazek J, et al. Transplantation of livers from hbc Ab positive donors into HBc Ab negative recipients: a strategy and preliminary results. Clin Transplant. 2001;15 Suppl 6:55–8.

    Article  PubMed  Google Scholar 

  32. Salizzoni M, Lupo F, Zamboni F, et al. Outcome of patients transplanted with liver from hepatitis C positive donors. Transplant Proc. 2001;33:1507–8.

    Article  PubMed  CAS  Google Scholar 

  33. Velidedeoglu E, Desai NM, Campos L, et al. Effect of donor hepatitis C on liver graft survival. Transplant Proc. 2001;33:3795–6.

    Article  PubMed  CAS  Google Scholar 

  34. Ghobrial RM, Steadman R, Gornbein J, et al. A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients. Ann Surg. 2001;234:384–93. discussion 93–4.

    Article  PubMed  CAS  Google Scholar 

  35. Saab S, Chang AJ, Comulada S, et al. Outcomes of hepatitis C- and hepatitis B core antibody-positive grafts in orthotopic liver transplantation. Liver Transpl. 2003;9:1053–61.

    Article  PubMed  Google Scholar 

  36. Wright TL, Donegan E, Hsu HH, et al. Recurrent and acquired hepatitis C viral infection in liver transplant recipients. Gastroenterology. 1992;103:317–22.

    PubMed  CAS  Google Scholar 

  37. Gane EJ, Portmann BC, Naoumov NV, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med. 1996;334:815–20.

    Article  PubMed  CAS  Google Scholar 

  38. Turner BL, Cade-Menun BJ, Condron LM, Newman S. Extraction of soil organic phosphorus. Talanta. 2005;66:294–306.

    Article  PubMed  CAS  Google Scholar 

  39. Condron CL, Porter R, Guo T, Kauzlarich SM. Crystal structures, Raman spectroscopy, and magnetic properties of Ba7.5Al13Si29 and Eu0.27Ba7.22Al13Si29. Inorg Chem. 2005;44:9185–91.

    Article  PubMed  CAS  Google Scholar 

  40. Mazzaferro V, Regalia E, Pulvirenti A, et al. Prophylaxis against HCV recurrence after liver transplantation: effect of interferon and ribavirin combination. Transplant Proc. 1997;29:519–21.

    Article  PubMed  CAS  Google Scholar 

  41. Chalasani N, Manzarbeitia C, Ferenci P, et al. Peginterferon alfa-2a for hepatitis C after liver transplantation: two randomized, controlled trials. Hepatology. 2005;41:289–98.

    Article  PubMed  CAS  Google Scholar 

  42. Singh N, Gayowski T, Wannstedt CF, et al. Interferon-alpha for prophylaxis of recurrent viral hepatitis C in liver transplant recipients: a prospective, randomized, controlled trial. Transplantation. 1998;65:82–6.

    Article  PubMed  CAS  Google Scholar 

  43. Carrion JA, Navasa M, Garcia-Retortillo M, et al. Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study. Gastroenterology. 2007;132:1746–56.

    Article  PubMed  CAS  Google Scholar 

  44. Castells L, Vargas V, Allende H, et al. Combined treatment with pegylated interferon (alpha-2b) and ribavirin in the acute phase of hepatitis C virus ­recurrence after liver transplantation. J Hepatol. 2005;43:53–9.

    Article  PubMed  CAS  Google Scholar 

  45. Ross AS, Bhan AK, Pascual M, Thiim M, Benedict Cosimi A, Chung RT. Pegylated interferon alpha-2b plus ribavirin in the treatment of post-liver transplant recurrent hepatitis C. Clin Transplant. 2004;18:166–73.

    Article  PubMed  Google Scholar 

  46. Samuel D, Bizollon T, Feray C, et al. Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study. Gastroenterology. 2003;124:642–50.

    Article  PubMed  CAS  Google Scholar 

  47. Berg CL, Steffick DE, Edwards EB, et al. Liver and intestine transplantation in the United States 1998–2007. Am J Transplant. 2009;9:907–31.

    Article  PubMed  CAS  Google Scholar 

  48. Selck FW, Grossman EB, Ratner LE, Renz JF. Utilization, outcomes, and retransplantation of liver allografts from donation after cardiac death: implications for further expansion of the deceased-donor pool. Ann Surg. 2008;248:599–607.

    PubMed  Google Scholar 

  49. Yamamoto S, Wilczek HE, Duraj FF, Groth CG, Ericzon BG. Liver transplantation with grafts from controlled donors after cardiac death: a 20-year follow-up at a single center. Am J Transplant. 2010;10:602–11.

    Article  PubMed  CAS  Google Scholar 

  50. Pine JK, Aldouri A, Young AL, et al. Liver transplantation following donation after cardiac death: an analysis using matched pairs. Liver Transpl. 2009;15:1072–82.

    Article  PubMed  Google Scholar 

  51. Grewal HP, Willingham DL, Nguyen J, et al. Liver transplantation using controlled donation after cardiac death donors: an analysis of a large single-center experience. Liver Transpl. 2009;15:1028–35.

    Article  PubMed  Google Scholar 

  52. Skaro AI, Jay CL, Baker TB, et al. The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: the untold story. Surgery. 2009;146:543–52. discussion 52–3.

    Article  PubMed  Google Scholar 

  53. Abt P, Crawford M, Desai N, Markmann J, Olthoff K, Shaked A. Liver transplantation from controlled non-heart-beating donors: an increased incidence of biliary complications. Transplantation. 2003;75:1659–63.

    Article  PubMed  Google Scholar 

  54. Mathur AK, Heimbach J, Steffick DE, Sonnenday CJ, Goodrich NP, Merion RM. Donation after cardiac death liver transplantation: predictors of outcome. Am J Transplant. 2010;10:2512–9.

    Article  PubMed  CAS  Google Scholar 

  55. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant. 2006;6:783–90.

    Article  PubMed  CAS  Google Scholar 

  56. Ison MG, Hager J, Blumberg E, et al. Donor-derived disease transmission events in the United States: data reviewed by the OPTN/UNOS Disease Transmission Advisory Committee. Am J Transplant. 2009;9:1929–35.

    Article  PubMed  CAS  Google Scholar 

  57. Kauffman HM, McBride MA, Cherikh WS, Spain PC, Delmonico FL. Transplant tumor registry: donors with central nervous system tumors1. Transplantation. 2002;73:579–82.

    Article  PubMed  Google Scholar 

  58. Myron Kauffman H, McBride MA, Cherikh WS, Spain PC, Marks WH, Roza AM. Transplant tumor registry: donor related malignancies. Transplantation. 2002;74:358–62.

    Article  PubMed  CAS  Google Scholar 

  59. Teperman L. Donor-transmitted diseases. Liver Transpl. 2010;16:S40–4.

    Article  Google Scholar 

  60. Olthoff KM, Merion RM, Ghobrial RM, et al. Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg. 2005;242:314–23. discussion 23–5.

    PubMed  Google Scholar 

  61. Hong JC, Yersiz H, Busuttil RW. Where are we today in split liver transplantation? Curr Opin Organ Transplant. 2011;16:269–73.

    Article  PubMed  Google Scholar 

  62. Trotter JF, Gillespie BW, Terrault NA, et al. Laboratory test results after living liver donation in the adult-to-adult living donor liver transplantation cohort study. Liver Transpl. 2011;17:409–17.

    Article  PubMed  Google Scholar 

  63. Jaeschke H. Molecular mechanisms of hepatic ­ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol. 2003;284:G15–26.

    PubMed  CAS  Google Scholar 

  64. Gao W, Bentley RC, Madden JF, Clavien PA. Apoptosis of sinusoidal endothelial cells is a critical mechanism of preservation injury in rat liver transplantation. Hepatology. 1998;27:1652–60.

    Article  PubMed  CAS  Google Scholar 

  65. Caldwell-Kenkel JC, Currin RT, Tanaka Y, Thurman RG, Lemasters JJ. Kupffer cell activation and endothelial cell damage after storage of rat livers: effects of reperfusion. Hepatology. 1991;13:83–95.

    PubMed  CAS  Google Scholar 

  66. Vajdová K, Smreková R, Kukan M, Lutterová M, Wsólová L. Bile analysis as a tool for assessing ­integrity of biliary epithelial cells after cold ischemia—reperfusion of rat livers. Cryobiology. 2000;41:145–52.

    Article  PubMed  Google Scholar 

  67. Clavien PA, Harvey PR, Strasberg SM. Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation. 1992;53:957–78.

    Article  PubMed  CAS  Google Scholar 

  68. Kupiec-Weglinski JW, Busuttil RW. Ischemia and reperfusion injury in liver transplantation. Transplant Proc. 2005;37:1653–6.

    Article  PubMed  CAS  Google Scholar 

  69. Jaeschke H. Reactive oxygen and ischemia/reperfusion injury of the liver. Chem Biol Interact. 1991;79:115–36.

    Article  PubMed  CAS  Google Scholar 

  70. Atalla SL, Toledo-Pereyra LH, MacKenzie GH, Cederna JP. Influence of oxygen-derived free radical scavengers on ischemic livers. Transplantation. 1985;40:584–90.

    Article  PubMed  CAS  Google Scholar 

  71. Menger MD. Microcirculatory disturbances secondary to ischemia-reperfusion. Transplant Proc. 1995;27:2863–5.

    PubMed  CAS  Google Scholar 

  72. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med. 1985;312:159–63.

    Article  PubMed  CAS  Google Scholar 

  73. Momii S, Koga A. Time-related morphological changes in cold-stored rat livers. A comparison of Euro-Collins solution with UW solution. Transplantation. 1990;50:745–50.

    Article  PubMed  CAS  Google Scholar 

  74. Gebhard MM, Bretschneider HJ, Gersing E, Preusse CJ, Schnabel PA, Ulbricht LJ. Calcium-free cardioplegia—pro. Eur Heart J. 1983;4(Suppl H):151–60.

    Article  PubMed  CAS  Google Scholar 

  75. Belzer FO, Southard JH. Principles of solid-organ preservation by cold storage. Transplantation. 1988;45:673–6.

    Article  PubMed  CAS  Google Scholar 

  76. Menasche P, Termignon JL, Pradier F, et al. Experimental evaluation of Celsior, a new heart preservation solution. Eur J Cardiothorac Surg. 1994;8:207–13.

    Article  PubMed  CAS  Google Scholar 

  77. Bessems M, Doorschodt BM, van Vliet AK, van Gulik TM. Machine perfusion preservation of the non-heart-beating donor rat livers using polysol, a new preservation solution. Transplant Proc. 2005;37:326–8.

    Article  PubMed  CAS  Google Scholar 

  78. Guarrera JV, Henry SD, Samstein B, et al. Hypothermic machine preservation in human liver transplantation: the first clinical series. Am J Transplant. 2010;10:372–81.

    Article  PubMed  CAS  Google Scholar 

  79. Moers C, Smits JM, Maathuis MH, et al. Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med. 2009;360:7–19.

    Article  PubMed  CAS  Google Scholar 

  80. Lee CY, Zhang JX, Jones Jr JW, Southard JH, Clemens MG. Functional recovery of preserved livers following warm ischemia: improvement by machine perfusion preservation. Transplantation. 2002;74:944–51.

    Article  PubMed  CAS  Google Scholar 

  81. Iwamoto H, Matsuno N, Narumi Y, et al. Beneficial effect of machine perfusion preservation on liver transplantation from non-heart-beating donors. Transplant Proc. 2000;32:1645–6.

    Article  PubMed  CAS  Google Scholar 

  82. Guarrera JV, Henry SD, Chen SW, et al. Hypothermic machine preservation attenuates ischemia/reperfusion markers after liver transplantation: preliminary results. J Surg Res. 2011;167:e365–73.

    Article  PubMed  Google Scholar 

  83. Guarrera JV, Karim NA. Liver preservation: is there anything new yet? Curr Opin Organ Transplant. 2008;13:148–54.

    Article  PubMed  Google Scholar 

  84. Kaizu T, Nakao A, Tsung A, et al. Carbon monoxide inhalation ameliorates cold ischemia/reperfusion injury after rat liver transplantation. Surgery. 2005;138:229–35.

    Article  PubMed  Google Scholar 

  85. Amersi F, Shen XD, Anselmo D, et al. Ex vivo exposure to carbon monoxide prevents hepatic ischemia/reperfusion injury through p38 MAP kinase pathway. Hepatology. 2002;35:815–23.

    Article  PubMed  CAS  Google Scholar 

  86. de Rougemont O, Lehmann K, Clavien PA. Preconditioning, organ preservation, and postconditioning to prevent ischemia-reperfusion injury to the liver. Liver Transpl. 2009;15:1172–82.

    Article  PubMed  Google Scholar 

  87. Tolboom H, Pouw RE, Izamis ML, et al. Recovery of warm ischemic rat liver grafts by normothermic extracorporeal perfusion. Transplantation. 2009;87:170–7.

    Article  PubMed  Google Scholar 

  88. Brockmann J, Reddy S, Coussios C, et al. Normothermic perfusion: a new paradigm for organ preservation. Ann Surg. 2009;250:1–6.

    Article  PubMed  Google Scholar 

  89. Fondevila C, Hessheimer AJ, Ruiz A, et al. Liver transplant using donors after unexpected cardiac death: novel preservation protocol and acceptance criteria. Am J Transplant. 2007;7:1849–55.

    Article  PubMed  CAS  Google Scholar 

  90. Henry SD, van der Wegen P, Metselaar HJ, Tilanus HW, Scholte BJ, van der Laan LJ. Simultaneous targeting of HCV replication and viral binding with a single lentiviral vector containing multiple RNA interference expression cassettes. Mol Ther. 2006;14:485–93.

    Article  PubMed  CAS  Google Scholar 

  91. Lehmann TG, Wheeler MD, Froh M, et al. Effects of three superoxide dismutase genes delivered with an adenovirus on graft function after transplantation of fatty livers in the rat. Transplantation. 2003;76: 28–37.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Abdominal Organ Transplantation and Molecular Therapies and Organ Preservation Research Laboratory, Department of Surgery, Columbia University Medical Center, New York, NY, USA

    Coney Bae B.S., Scot D. Henry Ph.D., Giridhar Vedula M.D. & James V. Guarrera M.D., F.A.C.S

Authors
  1. Coney Bae B.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Scot D. Henry Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Giridhar Vedula M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. James V. Guarrera M.D., F.A.C.S
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to James V. Guarrera M.D., F.A.C.S .

Editor information

Editors and Affiliations

  1. , College of Physicians & Surgeons, Departments of Anesthesiology, of Columbia University, New York, 10032, New York, USA

    Gebhard Wagener

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media New York

About this chapter

Cite this chapter

Bae, C., Henry, S.D., Vedula, G., Guarrera, J.V. (2012). The Marginal Liver Donor and Organ Preservation Strategies. In: Wagener, G. (eds) Liver Anesthesiology and Critical Care Medicine. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-5167-9_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-4614-5167-9_15

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4614-5166-2

  • Online ISBN: 978-1-4614-5167-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation